bluebird bio (BLUE) Reports Q1 Loss of $3.64/sh

bluebird bio (NASDAQ: BLUE) reported Q1 EPS of ($3.64), versus ($2.99) reported last year. Revenue for the quarter came in at $21.9 million, versus $12.5 million reported last year.

For earnings history and earnings-related data on bluebird bio (BLUE) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• The LGL Group (LGL) Misses Q2 EPS by 8c
• BofA Securities Downgrades Autohome Inc. (ATHM) to Underperform